For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260505:nRSE1135Da&default-theme=true
RNS Number : 1135D Melrose Industries PLC 05 May 2026
5ᵗʰ May 2026
Melrose Industries PLC
("Melrose" or the "Company")
Transaction in Own Shares
The Company announces today it has purchased the following number of its
ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in
the period from 27ᵗʰ April 2026 to 1ˢᵗ May 2026.
Date Venue Volume-weighted average price (p) Aggregated volume Lowest price per share (pence) Highest price per share (p)
27 April 2026 XLON 495.6587 63,000 490.2000 500.8000
28 April 2026 XLON 488.6622 63,000 485.0000 493.2000
29 April 2026 XLON 475.4272 63,000 469.9000 485.2000
30 April 2026 XLON 481.2739 63,000 476.0000 484.7000
1 May 2026 XLON 484.2822 63,000 479.3000 488.9000
The Company intends to hold the purchased shares in treasury.
Following the above transaction, the Company has 64,002,214 ordinary shares
in treasury and has 1,247,473,107 ordinary shares in issue (excluding
treasury shares).
Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No
596/2014 as it forms part of UK law, a full breakdown of the individual trades
made by the MLI on behalf of the Company as part of the buyback programme is
attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/1135D_1-2026-5-5.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1135D_1-2026-5-5.pdf)
For further information please contact:
Warren Fernandez Company
Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSSSFFIIEMSEEI
Copyright 2019 Regulatory News Service, all rights reserved